Search results
As of 2008, the most reliable way to predict whether a colorectal cancer patient will respond to one of the EGFR-inhibiting drugs was to test for certain “activating” mutations in the gene that encodes KRAS, which occurs in 30%–50% of colorectal cancers.
15 lis 2021 · Kirsten rat sarcoma viral oncogene homologue (KRAS) is the best-known oncogene with the highest mutation rate among all cancers and is associated with a series of highly fatal cancers,...
26 wrz 2024 · What is the KRAS mutation? An error in the KRAS gene is one type of lung cancer biomarker. It is called KRAS because it was first identified as causing cancer in Kirsten rat sarcoma virus.
15 lis 2021 · As the most frequently mutated oncogene, Kirsten rat sarcoma viral oncogene homologue (KRAS) has attracted substantial attention. The understanding of KRAS is constantly being updated by numerous studies on KRAS in the initiation and progression of cancer diseases.
KRAS is the most frequently mutated proto-oncogene in human cancers, and mutated KRAS remains locked in an active state, relaying uncontrolled proliferative signals. Jonathan M. Ostrem et al. identified that oncogenic mutations result in conformational change and functional activation of RAS proteins by impairing both intrinsic GTPase activity ...
Mutated RAS is constitutively activated and persistently turned "on" thereby enhancing downstream signaling and leading to tumorigenesis. Various attempts to inhibit Kras in the past were unsuccessful.
22 mar 2021 · Mutational activation of KRAS promotes the initiation and progression of cancers, especially in the colorectum, pancreas, lung, and blood plasma, with varying prevalence of specific...
